A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)

Original registry description

This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.